Rentokil Initial Share Discussion Threads

[hedgehog 100] 22/8/2019 13:02

AUCThtung!

Another main market investment shell, valued at well under a million quid, and with £920K. of cash at its final year end (final results 29.4.19).


Auctus Growth PLC (AUCT) 31p Market cap. £0.87M.





29/04/2019 07:00 UK Regulatory (RNS & others) Auctus Growth Plc Final Results
" ... I am very conscious of our lack of performance in regards to securing a suitable reverse takeover candidate. Myself and the Board are very appreciative of your patience and remain eager to find a transaction that will ultimately reward all shareholders. In that regard I can confirm that the Board is currently assessing a potential transaction and whilst there can be no guarantee the transaction will proceed the Board is encouraged by the initial due diligence being carried out. ... "

[philanderer] 20/8/2019 08:54

Rentokil Initial was down 1.0%, after RBC Capital cut the pest control company to Sector Perform from Outperform


Alliance News

[hedgehog 100] 10/8/2019 13:49

pilot486 May '19 - 04:43 - 925 of 936(premium)
"MILA worth a look. Valued below cash and new director in place."


Thanks Pilot - looks interesting.

A main market investment shell, valued at barely a third of a million quid, and with £573K. of cash at the interim period end (interim results 29.3.19).


Mila Resources PLC (MILA) 1.4p Market cap. £0.34M.





29/03/2019 07:00 UK Regulatory (RNS & others) Mila Resources PLC Interim Results
" ... We recently mutually terminated a proposed reverse takeover of Capital Metals Limited, however we continue to see a strong flow of potential Acquisition opportunities. The Board of Directors, together with the Company's advisers, are constantly evaluating these opportunities to ensure that we secure and execute the right transaction.
I look forward to reporting our progress to you over the coming the months. ... "

[hedgehog 100] 31/7/2019 15:57

A belated happy 18th. 'shell birthday' to HWC!

Just think of all the things it can now do: vote, buy alcohol ... maybe even finally get a RTO!!

28/06/2001 15:25 UK Regulatory (RNS & others) Final Results
LSE:HWC
Highway Capital
"The Company is now effectively a cash shell and as such is seeking suitable acquisitions. Your directors are in the process of searching for a suitable business."

[haydock] 10/7/2019 11:36

Hedgehog 100
Tern has revealed some of the details of their main companies.
[FVR]

[DA]


They hold 56% of DA. & 34% of FVR.


Finally revealing some of the amazing potential.

Also an overview of the company:



Cheers Hay.

[philanderer] 27/6/2019 08:17

27th june Barclays overweight tp 410p up from 350p

[hedgehog 100] 27/6/2019 07:11

Well done!

[yogaboy] 27/6/2019 07:09

Grabbed a few on the dip yesterday, so I'm in now.

[hedgehog 100] 23/6/2019 12:16

IQ-AI Ltd. (IQAI) 3.9p Market cap. £4.69M.





Thanks yogaboy! Sorry you didn't see it earlier: I tipped it at 1.2p on 5th. May, and after closing at 1.4p on May 9th. it drifted back, and as recently as last week (Tuesday 11th. June) it was back at 1.2p.

Since then 103.6 million shares have been traded, out of 120.35M. shares in issue, of which 67.76M. are available.

This has been triggered by two things:

1. 12/06/2019 07:00 UKREG IQ-AI Limited Business Development Agreement with CorTechs Labs


CorTech has marketing agreements with very big players like GE Healthcare and others.

2. A video interview with IQAI's David Smith on Proactive Investors:
"IQ-AI on track to double sales in 2019 as it inks deal with CorTechs Labs
15:56 12 Jun 2019
IQ-AI Limited’s (LON:IQAI) David Smith caught up with Proactive London's Andrew Scott after announcing that Imaging Biometrics has signed a non-exclusive business development and sales deal with brain analysis firm CorTechs Labs.
Smith says the deal gives them extended and immediate sales representation in the US and other international markets.
He adds that product sales have continued to accelerate in 2019 and as a result they're expecting full year 2019 numbers to be more than double those for 2018."

ADVFN won't allow links to Proactive Investors to show, but here are a couple of links to the video that work:



FDA approval for IQAI's StoneChecker software is expected by the end of June, i.e. next week.


Note that David Smith sold his last company for $178M., and before that played a leading role in driving sales at Biocompatibles from 0 to over £40M.
(Biocompatibles was acquired by BTG in 2010 for £177M.)

And last August David Smith did a series of investor lunches, introducing himself, explaining the company products and future pipeline and laying out his vision for the company.

Here are a few points from one of those presentations:
• His deal is largely equity based, so he is aligned with us.
• Whilst StoneChecker has great potential, the real winner could be the brain scanning software of IB, which should be extended to other areas. Liver was mentioned as achievable with minor tweaks.
• His plan is to deliver revenues of $20M. to $30M. annual within the next few years on existing products but double that with 'planned' products.
• He mentioned the possible need to land grab in order to build the business quickly at which point they would probably be taken out by GE or Phillips who provide the hardware but have poor software that is 20 years old in many cases.

[yogaboy] 20/6/2019 12:22

Wow Hedgehog, not checked in here for a while and just saw your IQAI piece from 46 days ago. Pretty good return for 46 days, good call! Wish I'd seen it earlier!

[hedgehog 100] 09/5/2019 18:17

Haydock,

Yes, I'm expecting IQAI to raise additional funds in a few months.

And I'm also expecting a period of very positive IQAI newsflow in the near future, driving the share price to much higher levels ahead of that fundraising.

In fact, I would prefer a situation like this to one where a company doesn't need to raise funds for quite a while, and is happy to let the share price drift in the interim.

IQAI did actually conduct a fundraising in March though, which bodes well for the price of the next fundraising.

IQAI's March 2019 fundraising had two major positives:
1. The fundraising conversion price of 2p was at a massive premium (56.86%) to the then IQAI share price (1.275p).
2. The investment of the two CEO's was akin to massive directors share buying, a huge vote of confidence in the company, especially at such a massive premium.

11/03/2019 07:00 UKREG IQ-AI Limited Issue of Convertible Loan Notes
"IQ-AI is pleased to announce that the Company has issued GBP268,500 in nominal amount of 6% unsecured convertible loan notes 2024, convertible into 13,425,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 2 pence per share ("CLNs"). The funds raised as a result of the issue of the CLNs will be used to provide additional working capital for the Company. The funds raised enables the Company to fully execute its current business plan and shareholders should take comfort that the Company is now able to fully execute its current strategic objectives, following this, initially, non-dilutive fundraise.
Trevor Brown, Chairman of the Company, has subscribed for GBP250,000 of the CLNs and Michael Schmainda, Chief Executive Officer of the Company's 100% owned subsidiary, Imaging Biometrics LLC, has subscribed for GBP18,500 of the CLNs. ..."



There are some similarities with TERN near its medium term low of 2p.

And TERN took advantage of its subsequent share price rise in 2018 to raise funds at far less dilution than otherwise -

08/05/2018 07:01 UK Regulatory (RNS & others) Tern PLC: Equity Fundraise
Tern Plc (AIM:TERN), the investment company specialising in the Internet of
Things ("IoT"), is pleased to announce that it has raised GBP1,750,000 before
expenses through an unconditional placing of 9,459,460 new ordinary shares
of 0.02p each at a price of 18.50 pence per ordinary share (the "Placing")
with a single institutional investor, utilising the existing share
authorities granted at the 2018 AGM. ...


25/07/2018 07:01 UK Regulatory (RNS & others) Tern PLC: Equity Fundraise of c. GBP2.9m
Tern Plc (AIM:TERN), the investment company specialising in the Internet of
Things ("IoT"), is pleased to announce that it has raised approximately GBP2.9
million before expenses through an unconditional placing of 11,192,307 new
ordinary shares of 0.02p each at a price of 26 pence per ordinary share (the
"Placing"), utilising the existing share authorities granted at the 2018
AGM. ...

[haydock] 07/5/2019 18:22

I have had a look at your tip. Interesting tech, in a good area, but will need more cash?
Tern is now adding companies in that area, & this looks to have a cash shortage.

Tern has been an education in that direction.

Suggest you look at the beauty Tern has 35% of these days, if you want to see a winner in the same area.
That's one reason the holders is now excited about Tern.

hxxps://www.fundamentalsurgery.com/

[haydock] 07/5/2019 16:43

Hedgehog 100

I hope you have your eyes on the tern Chart.
Just beginning to stretch it's wings ?

Cheers Hay.

[hedgehog 100] 07/5/2019 14:37

Purple11,

Zamano paid a cash distribution to shareholders in February of this year, of just over 3p per share.

A final distribution is expected to be paid out this summer.

[purple11] 06/5/2019 05:22

Hedge your last "other"tip on this thread was ZMNO at 4p

what happened to that?

[pilot48] 06/5/2019 03:43

MILA worth a look. Valued below cash and new director in place.

[rjmahan] 05/5/2019 21:24

PVCS might be worth a look post distribution

[hedgehog 100] 05/5/2019 14:20

My last 'tip' on this thread was on 20.12.17: TERN at 2.0p (see post 919 above).
Within six months it had more than 20-bagged, to over 40p.

Now it's time for a follow-up: a main-listed micro cap., that has a very exciting story:

IQ-AI Ltd. (IQAI) 1.2p Market cap. £1.44M.

[philanderer] 18/4/2019 22:55

Peel Hunt reiterating 'hold' tp 381p up from 345p after today's update

[connorcampbell] 12/4/2019 12:33

!YOUTUBEVIDEO:FpMGiEiiGE8:
Can Rentokil Initial exterminate any sellers with Thursday’s Q1 trading update?

A heat-wave led rise in rats, wasps and flies gave the firm’s full year figures a boost in February, with organic revenue growth at its Pest Control division up 4.8%, ahead of the group’s 3.7% increase. Total revenue, meanwhile, rose 4.1% at constant exchange rates to £2.47 billion, with adjusted pre-tax profit climbing 8.8% to £308 million.

The company ended February’s report by stating that following a ‘good start to the year’ it anticipates ‘a slight increase in market expectations for 2019’, something investors will want further word on in Thursday’s first quarter statement.

Read what Spreadex analysts have to say, or watch a 60 second earnings preview video, here:

[connorcampbell] 12/4/2019 12:33

Can Rentokil Initial exterminate any sellers with Thursday’s Q1 trading update?

A heat-wave led rise in rats, wasps and flies gave the firm’s full year figures a boost in February, with organic revenue growth at its Pest Control division up 4.8%, ahead of the group’s 3.7% increase. Total revenue, meanwhile, rose 4.1% at constant exchange rates to £2.47 billion, with adjusted pre-tax profit climbing 8.8% to £308 million.

The company ended February’s report by stating that following a ‘good start to the year’ it anticipates ‘a slight increase in market expectations for 2019’, something investors will want further word on in Thursday’s first quarter statement.

Read what Spreadex analysts have to say, or watch a 60 second earnings preview video, here: hxxps://spreadex.com/?tid=389659

[philanderer] 22/3/2019 09:15

Pell Hunt downgrades from 'add' to 'hold' ...tp 345p

[philanderer] 18/3/2019 11:09

Goldmans 'neutral'... tp 400p cut from 420p

[wattene] 05/3/2019 11:37

Government Petition to Ban shorting of London AIM stocks.

The AIM stock market is where smaller companies list their shares rather than using the prohibitively expensive main London Stock Market. This is an important market for the growth of smaller UK companies.

In challenging times, shorters seek to borrow the company's shares from a holder for a consideration and to buy them at a later date. They immediately sell these shares which, due to the relative illiquid market, sends the price much lower and hence the shorters can buy them at that lower price - pocketing the difference. The only beneficiaries are the shorters and the market makers with the losers being the reputable company and it's bona fide investors.

[philanderer] 05/3/2019 09:47

5th march JP Morgan Caz overweight tp 370p up from 350p